Livestock Antibiotic Trade-offs: Welfare and Resistance

The intersection of antimicrobial resistance and livestock welfare requires nuanced approaches that protect both individual animal welfare and public health.

Key Facts

WHO has classified 34 antibiotics as critically important for human medicine, many of which are also used in livestock
Colistin, a last-resort human antibiotic, was used extensively in Asian livestock until resistance emerged
Denmark banned growth-promotion antibiotic use in 1999 and saw no long-term production losses after adaptation
Metaphylaxis - treating entire groups when some animals show disease - is a welfare-positive alternative to growth promotion
Antibiotic stewardship programs require sick animals to be treated while preventing routine prophylactic use

Welfare Considerations

The antibiotic reduction imperative creates genuine welfare tension: restricting antibiotics benefits public health but must not translate to individual animals suffering treatable bacterial disease. Welfare-positive antibiotic stewardship uses antibiotics when sick animals need them while eliminating routine preventive use that drives resistance. This requires addressing the underlying conditions making prophylactic antibiotics necessary - overcrowding, poor hygiene, and inadequate nutrition. The welfare case and the stewardship case both point toward higher-welfare production systems as the solution.

What You Can Do

Support farms with antibiotic stewardship programs that treat sick animals while eliminating prophylactic use
Choose products certified to antibiotic-responsible production standards
Advocate for government policies supporting farmer transitions away from prophylactic antibiotic dependence
Support one-health approaches linking human and animal health in antibiotic governance
Learn about the distinction between therapeutic and prophylactic antibiotic use in livestock